CVD, its relationship to the CAC score is less clear. 2 For example, endurance athletes with high fitness have been reported to have greater CAC scores than age-and risk factorematched controls. 4 Moreover, a recent study reported decreased mortality in highly fit individuals with increased CAC scores. 5 Such paradoxical findings suggest that the association between CAC score and fitness is more complex than previously believed. 2 These conflicting data may be partially attributed to differing methodologies employed for fitness assessment and the quantitation of CAC. Most previous studies regarding these associations have relied primarily on Agatston scores, rather than advanced CAC volume and density scores. Accordingly, we sought to determine whether high fitness, directly measured by expired gas analysis as an objective index of fitness, expressed as VO 2peak , correlated with varied CAC scoring indices.
Although the CAC volume score is positively associated with CVD risk, it appears that CAC density is inversely related to the risk of incident cardiovascular events.
1 Elevated CAC density scores may suggest plaque stabilization; thus, greater CAC density may be associated with more stable coronary disease and a reduced likelihood of plaque rupture. 1 Accordingly, the Agatston score alone may be inadequate to predict CVD risk, given the inverse relationship between CAC density and CVD risk. 1 In the present study, higher fitness was inversely related to advanced CAC by Agatston and volume scores but directly related to advanced CAC density, suggesting that fitness may be associated with CAC plaque morphology. Collectively, these data suggest that high fitness may attenuate coronary calcification and increase plaque stabilization, potentially reducing the risk of cardiovascular events in men. Reinitiation of Statin Therapy After Discontinuation: A Meta-analysis
To the Editor: The efficacy of statins in the prevention of cardiovascular disease has been well established. 1 However, many patients for whom statins are prescribed do not adhere to their medication regimen, and discontinuation from therapy is high, with over 30% of users discontinuing within 1 year. 2 Statin discontinuation has been associated with poor clinical outcomes, with important economic implications. 3 Although patients discontinuing statin therapy may restart, to our knowledge no published systematic review has assessed reinitation rates. Understanding the patterns of reinitiation is important because the benefits of statin treatment accrue over time.
Methods. We conducted a systematic review to assess statin reinitiation rates by searching MEDLINE, EMBASE, CINAHL, and PsycINFO from inception to October 30, 2017, using terms including statins or HMG-CoA reductase inhibitors and discontinuation or persistence or reinitiation or resumption. The review followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines (Supplemental Table, available online at http://www.mayoclinicproceedings. org) and studies were appraised using a modified version of the National Institutes of Health Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. 4 The proportion of statin discontinuers who reinitiated were pooled across studies through random effects meta-analysis. The between-study heterogeneity was quantified via the I 2 statistic. The presence of publication bias was assessed by direct observations of funnel plots and quantified with Egger's regression test. 5 The robustness of pooled estimates was determined through leave-one-out sensitivity assessments. The limitation of our meta-analysis is that the certainty in the pooled estimates (using the GRADE [Grading of Recommendations, Assessment, Development and Evaluations] approach) is very low due to substantial heterogeneity across the studies.
Conclusion. Our results demonstrate that a significant proportion of statin users restart following discontinuation. Although there is no universally accepted criteria for establishing statin discontinuation, the proportions restarting following a period of treatment cessation is encouraging. Nonetheless, interventions are needed to address the factors that promote discontinuation in order to avert cycles of treatment interruptions even among reinitiators. This focus is essential if the intended cardiovascular benefits of statin treatment are to be realized.
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